Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis

被引：0
|
作者：
Gordon R Bernard
William L Macias
David E Joyce
Mark D Williams
Joan Bailey
Jean-Louis Vincent
机构：
[1] Pulmonary and Critical Care,Director, Division of Allergy
[2] Vanderbilt University School of Medicine,Head, Department of Intensive Care
[3] Medical Director,undefined
[4] Eli Lilly and Company,undefined
[5] Clinical Research Physician,undefined
[6] Eli Lilly and Company,undefined
[7] Clinical Research Associate,undefined
[8] Eli Lilly and Company,undefined
[9] Erasme University Hospital,undefined
来源：
Critical Care | / 7卷
关键词：
activated protein C; drotrecogin alfa (activated); mortality; safety; severe sepsis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis
    Bernard, GR
    Macias, WL
    Joyce, DE
    Williams, MD
    Bailey, J
    Vincent, JL
    [J]. CRITICAL CARE, 2003, 7 (02) : 155 - 163
  • [2] The safety of drotrecogin alfa (activated) in pediatric patients with severe sepsis
    Goldstein, B
    Williams, M
    Wang, DZ
    Angle, R
    Giroir, B
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (12) : A152 - A152
  • [3] Drotrecogin alfa (activated): the treatment for severe sepsis?
    Vincent, Jean-Louis
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (11) : 1763 - 1777
  • [4] Drotrecogin Alfa (Activated) in the Treatment of Severe Sepsis
    Vincent, Jean-Louis
    [J]. CURRENT DRUG SAFETY, 2007, 2 (03) : 227 - 231
  • [5] Drotrecogin alfa (activated) treatment of older patients with severe sepsis
    Ely, EW
    Angus, DC
    Williams, MD
    Bates, B
    Qualy, R
    Bernard, GR
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (02) : 187 - 195
  • [6] Readministration of drotrecogin alfa (activated) in an adult with severe sepsis
    Scipione, Marco R.
    Nogid, Boris
    Davanos, Evangelia
    DiGregorio, Robert V.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (18) : 1711 - 1715
  • [7] Safety of drotrecogin alfa (activated) in adult patients with severe sepsis: Comparison of global enhance to prowess
    Beale, R
    Wright, TJ
    Wong, K
    Vincent, JL
    Bernard, G
    [J]. CHEST, 2003, 124 (04) : 102S - 103S
  • [8] The development of drotrecogin alfa (activated) for the treatment of severe sepsis
    Macias, WL
    Yan, SB
    Grinnell, BW
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2004, 27 (05): : 360 - 370
  • [9] Timing of drotrecogin alfa (activated) treatment in severe sepsis
    Choi, Goda
    de Pont, Anne-Cornelie J. M.
    Schultz, Marcus J.
    [J]. CRITICAL CARE, 2006, 10 (04):
  • [10] Timing of drotrecogin alfa (activated) treatment in severe sepsis
    Goda Choi
    Anne-Cornélie JM de Pont
    Marcus J Schultz
    [J]. Critical Care, 10
12345